Form D · Other Technology
Solstice Medical, LLC
Indianapolis, IN · CIK 0001524981
Offering snapshot reported Jan 21, 2016 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 18, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 21, 2016 | Initial | $500,000 | No comparison | 4 | SEC filing |
| May 27, 2014 | Amendment | $1,187,000 | $75,000vs Mar 6, 2014 | 3 | SEC filing |
| Mar 6, 2014 | Initial | $1,112,000 | No comparison | 2 | SEC filing |
| Jul 26, 2011 | Initial | $200,000 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-255680
convertible debt
Source: Form D, filed Jan 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Clark | Director |
| Steve Hourigan | Director |
| Todd Melioris | Director, Executive |
| Niles Noblitt | Director |
| Michael Quinn | Director |
| Dan Sands | Director, Executive |
| Daniel L. Sands | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2020 West 86th Street Suite 304
Indianapolis, IN, 46260
Indianapolis, IN, 46260